ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.58
0.14%
US Tech 100
17,618.80
0.05%
S&P 500
5,187.70
0.13%
US Dollar vs CAD
1.37542
0.15%
Bitcoin
62,512.94
0.29%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. TC BioPharm Holdings PLC (TCBP)

  7. TC BioPharm Holdings PLC (TCBP) News

TCBP TC BioPharm Holdings PLC

1.18
-0.27 (-18.62%)
May 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
TC BioPharm Holdings PLC TCBP NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.27 -18.62% 1.18 18:59:25
Open Price Low Price High Price Close Price Previous Close
1.60 1.06 1.60 1.23 1.45
more quote information »

Recent News

Date Time Source Heading
5/06/202412:01PRNUSTC BioPharm Announces Exercise of Warrants for £3.1 Million..
5/06/202407:30PRNUSTC BioPharm Announces Execution of Second Non-Binding Letter..
4/04/202407:32PRNUSTCBP Announces Execution of Non-Binding Letter of Intent for..
4/02/202407:30PRNUSTCBP Increasing Treatment Capacity with Expanded..
3/19/202407:30PRNUSTCBP Adjourns General Meeting Until a Later Date
3/18/202407:30PRNUSTCBP Announces Exercise of Series D Warrants For Cash
3/06/202405:30EDGAR2Form 8-K - Current report
3/01/202407:30PRNUSBryan Kobel, CEO of TCBP, Appears on Nationally Syndicated..
2/27/202416:15PRNUS/C O R R E C T I O N -- TC BioPharm/
2/27/202407:30PRNUSTCBP Announces Shareholder Update Call on March 5th 2024
2/22/202408:32PRNUSTCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK..
2/20/202405:05EDGAR2Form DEF 14A - Other definitive proxy statements
2/15/202407:30PRNUSTC BioPharm Management to Participate at Upcoming 7th..
2/14/202413:48EDGAR2Form 8-K - Current report
2/14/202407:30PRNUSTCBP Provides Shareholder Update and Highlights Upcoming..
2/09/202414:26EDGAR2Form PRE 14A - Other preliminary proxy statements
1/29/202408:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/29/202407:30PRNUSTC BioPharm Chief Executive Officer, Bryan Kobel Featured on..
1/18/202407:30PRNUSTC BioPharm to Present at the Sequire Investor Summit
1/04/202407:46EDGAR2Form 8-K - Current report
1/04/202407:30PRNUSTC BioPharm Regains Compliance with Nasdaq Minimum Bid Price..
1/03/202407:30PRNUSTC BioPharm Announces Additional Cost Reduction Steps to..
12/22/202307:30PRNUSTC BioPharm Announces Closing of $3.5 Million Public..
12/21/202316:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/19/202307:00PRNUSTC BioPharm Announces Pricing of $3.5 Million Public..
12/18/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
12/18/202310:15PRNUSTC BioPharm Announces Formation of Commercial Development..
12/14/202316:20EDGAR2Form F-1/A - Registration statement for certain foreign..
12/13/202308:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/13/202305:30PRNUSTC BioPharm Announces Plan to Implement ADS Ratio Change
11/27/202307:45PRNUSTC BioPharm Announces FDA Clearance of Phase 1B IND for..
11/14/202309:00PRNUSTC BioPharm Announces Successful Completion of Safety Cohort..
11/08/202315:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/02/202312:30PRNUSTC BioPharm Announces Streamlined Efficiencies and Reduces..
11/02/202312:11EDGAR2Form F-3/A - Registration statement by foreign private..
11/02/202311:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202307:00PRNUSTC BioPharm Selects Excellos as CDMO in Anticipation of..
10/23/202307:00PRNUSTC BioPharm Announces Submission of Investigational New Drug..
9/29/202315:05EDGAR2Form F-3 - Registration statement by foreign private issuers
9/27/202307:00PRNUSTC BioPharm to Present at the LD Micro Main Event XVI
9/05/202307:30PRNUSTC BioPharm Announces Grant Funding in Collaboration with..
9/01/202316:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/31/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/29/202307:30PRNUSTC BioPharm to Present at H.C. Wainwright 25th Annual Global..
8/28/202316:25EDGAR2Form F-1 - Registration statement for certain foreign..
8/22/202315:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/31/202307:30PRNUSTC BioPharm Maintains Nasdaq Listing
7/31/202307:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/24/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/10/202316:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

NASDAQ
TCBP
TC BioPharm
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved